NuGen Medical Devices Inc. (TSXV:NGMD)

Market Cap	4.54M -71.3%
Revenue (ttm)	589.43K -22.7%
Net Income	-2.12M
EPS	-0.01
Shares Out	227.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,800
Average Volume	118,605
Open	0.0250
Previous Close	0.0200
Day's Range	0.0200 - 0.0250
52-Week Range	0.0200 - 0.0950
Beta	1.65
RSI	33.60
Earnings Date	Apr 30, 2026

About NuGen Medical Devices

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered i...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Lin Liang
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NGMD

Financial Performance

In 2024, NuGen Medical Devices's revenue was 1.01 million, an increase of 204.73% compared to the previous year's 331,403. Losses were -5.23 million, -44.18% less than in 2023.